Company Filing History:

5 out of 6,662

Hoechst Aktiengesellschaft

patents

4 out of 340

Behringwerke Aktiengesellschaft

where one patent can have more than one assignee

Years Active: 1986-1998

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5849799 - Use of deoxyspergualin for preparing a pharmaceutical for treating (1998-12-15),

2. 5780592 - Compositions comprising lipoproteins and crotonamide derivatives (1998-07-14),

3. 5561119 - Glycosylated prodrugs, their method of preparation and their uses (1996-10-01),

4. 4847299 - Use of 15-deoxyspergualine as a pharmaceutical (1989-07-11),

5. 4762848 - 1,3-thiazoles and their use as immunomodulators (1988-08-09),

6. 4701452 - Use of cephem compounds as immunomodulators (1987-10-20),

7. 4699912 - Use of Lycorine as an immunosuppressor (1987-10-13),

8. 4603137 - Immunosuppressive chromone alkaloid (1986-07-29),

9. 4578399 - Use of the diterpene derivative forskolin for immunostimulation (1986-03-25),

Title: The Innovations of Hans-Ulrich Schorlemmer

Introduction

Hans-Ulrich Schorlemmer is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases and immunological disorders. With a total of 9 patents to his name, Schorlemmer's work has had a profound impact on medical science.

Latest Patents

Among his latest patents is the use of deoxyspergualin for preparing a pharmaceutical aimed at treating hyperreactive inflammatory diseases in both humans and animals. This method involves administering a pharmaceutically effective amount of deoxyspergualin. Another significant patent involves compositions comprising lipoproteins and crotonamide derivatives, which are suitable for treating immunological disorders, cancer, or in transplantation.

Career Highlights

Schorlemmer has worked with prominent companies such as Hoechst Aktiengesellschaft and Behringwerke Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Gerhard Dickneite and Hans-Harald Sedlacek. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Hans-Ulrich Schorlemmer's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific research. His patents and collaborations reflect a career dedicated to addressing critical medical challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.